ANG Lifesciences India (BOM:540694) ROCE % : -13.65% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ANG Lifesciences India's annualized ROCE % for the quarter that ended in Dec. 2023 was -13.65%.

ANG Lifesciences India ROCE % Historical Data

The historical data trend for ANG Lifesciences India's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India ROCE % Chart

ANG Lifesciences India Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

29.44

27.68

27.74

69.87

11.41

ANG Lifesciences India Quarterly Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															2.77	-16.22	15.93	-1.21	-13.65

ANG Lifesciences India ROCE % Calculation

ANG Lifesciences India's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	138.175	/	( ( (2910.304 - 1662.893)	+	(2797.029 - 1622.84) )	/ 2 )
	=	138.175	/	( (1247.411	+	1174.189)	/ 2 )
	=	138.175	/	1210.8
	=	11.41 %

ANG Lifesciences India's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-154.16	/	( ( (2693.367 - 1564.265)	+	(0 - 0) )	/ 1 )
	=	-154.16	/	( ( 1129.102	+	0 )	/ 1 )
	=	-154.16	/	1129.102
	=	-13.65 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

ANG Lifesciences India (BOM:540694) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

ANG Lifesciences India ROCE % Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

ANG Lifesciences India (BOM:540694) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001

Website

https://www.anglifesciences.com

ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines